Fennec Pharmaceuticals Inc.
FENCHealthcareNASDAQBiotechnology
Scan Results
Daily timeframeFennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The $353.5M market capitalization puts FENC squarely in small-cap range for its industry. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients.
Market Cap
$353.5M
Beta
1.23
P/E (TTM)
—
P/E (Fwd)
10.63
EPS (TTM)
$-0.12
EPS (Fwd)
$0.95
ROE
-18.6%
ROA
-1.2%
Cash
$41.2M
Total Debt
$0
Free CF
$1.1M
52W Change
12.1%
Annual Financials
Cash vs Debt
Where FENC stands vs its 150-day and 200-day moving averages
As of the October 19, 2026 close, FENC finished 5.72% above its 150-day moving average ($9.44) and 10.15% above its 200-day moving average ($9.06). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is FENC overbought or oversold?
At the October 19, 2026 close, FENC's RSI(14) was 35.3, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Fennec Pharmaceuticals Inc. reports $41.2M in cash and $0 in total debt. The company generates $1.1M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -18.6%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $1.5M (2022) to $44.6M (2025), reflecting a 2808% increase over the period.
Investors considering Fennec Pharmaceuticals Inc. should weigh the typical risks associated with FENC's sector, size, and financial profile against their own risk tolerance and investment objectives. No single metric tells the full story. Reviewing FENC's risk profile alongside its fundamentals and technical indicators provides a more complete picture.